platinum has been researched along with 3-aminopyridine-2-carboxaldehyde thiosemicarbazone in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdul-Karim, FW; Abulafia, O; Bonebrake, AJ; Fanning, J; Kunos, C; Radivoyevitch, T; Usha, L | 1 |
1 trial(s) available for platinum and 3-aminopyridine-2-carboxaldehyde thiosemicarbazone
| Article | Year |
|---|---|
Ribonucleotide reductase inhibition restores platinum-sensitivity in platinum-resistant ovarian cancer: a Gynecologic Oncology Group Study.
Topics: Adult; Aged; Cell Line, Tumor; Cell Survival; Deoxycytosine Nucleotides; DNA Damage; Drug Resistance, Neoplasm; Enzyme Inhibitors; Female; Gynecology; Histones; Humans; Immunoblotting; Medical Oncology; Middle Aged; Ovarian Neoplasms; Platinum; Pyridines; Ribonucleotide Reductases; Thiosemicarbazones; Treatment Outcome | 2012 |